ACOG released its own 2026 immunization schedule for pregnant people, endorsing vaccines for COVID-19, RSV, influenza, and Tdap, signaling a break from CDC-aligned guidance.

The new guidance has been endorsed by 13 other professional and medical societies and follows ongoing debates and legal challenges related to vaccine schedules and government recommendations.

The move reflects friction between health professional groups and the CDC amid Kennedy-era vaccine policy changes and related lawsuits challenging policy actions.

A March 2026 federal court ruling blocked many Kennedy-initiated vaccine changes, leaving the CDC’s ACIP in limbo, with HHS appealing; ACOG’s independent guidance follows these tensions.

Additional vaccines (pneumococcal, meningococcal, hepatitis A, and hepatitis B) may be needed for women with certain risk factors, and counseling with a healthcare provider is advised.

Healthcare providers report vaccine hesitancy and misinformation among patients, with clear, evidence-based information from professional bodies seen as crucial to counter misinformation.

ACOG officials say the recommendations aim to reduce confusion and are grounded in rigorous reviews of efficacy and safety data.

Providers note social-media-fueled confusion and value ACOG’s clarified guidance to help patients navigate conflicting recommendations.

The article highlights ongoing legal challenges and tensions around vaccine recommendations and committee memberships within CDC advisory processes.

There is a perceived rise in vaccine hesitancy, driving professional groups to emphasize accurate, evidence-based information to aid patient decision-making.

Press briefings featuring leaders from ACOG, AAP, and AAFP stressed that OB-GYNs can address vaccine skepticism during regular prenatal visits.

ACOG leadership frames immunizations as essential to prepregnancy, prenatal, and postpartum care, positioning OB-GYNs as key to countering misinformation and guiding patient decisions.